Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy

NCT00793975 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

BIOLOGICAL: IMC-1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B
BIOLOGICAL: 1121B

Sponsor

Eli Lilly and Company